Kythera Conference Call Tomorrow

[It's2014ComeOnAlready]

Bimatoprost needs to become available NOW. I can't wait 2 more years on fin for Set.

[FearTheLoss]

All is needs is POC then phase III. so realistically we are 2-4 years.

[Keki]

POC early 2016, wtf we will never see seti in the market before 3 years at this rate....

[FearTheLoss]

Yeah we need to know dosage..someone needs to ask this.

[Swooping]

So it's going to be an oral therapy after all...they're calling it "kyth-105"

Oral is nice though, convenient in my opinion. The safety profile seems excellent anyway. Do you happen to know at what dosage they will be testing it?

[It's2014ComeOnAlready]

So it's going to be an oral therapy after all...they're calling it "kyth-105"

[joel203]

I would rather school Cotsarelis how he can stop that big ass vertex balding of him! With some actual proven treatments !

this is going to be funny… make sure you record

[Hairismylife]

Swooping! You should call them and school them with your knowledge!

Lol!!!!Swooping your show time.

[Swooping]

Swooping! You should call them and school them with your knowledge!

I would rather school Cotsarelis how he can stop that big ass vertex balding of him! With some actual proven treatments !

[sdsurfin]

Haha totally. And please record it too.

[It's2014ComeOnAlready]

Swooping! You should call them and school them with your knowledge!

[KO1]

KYTHERA Biopharmaceuticals Announces 2015 Outlook Call

http://www.kythera.com/kythera-biopharmaceuticals-announces-2015-outlook-call/

Westlake Village, Calif., March 19, 2015 – KYTHERA Biopharmaceuticals, Inc. (NASDAQ: KYTH) today announced it will host a 2015 Outlook investor call and webcast at 4:30 p.m. ET on Thursday, March 26, 2015.

Individuals interested in participating in the call should dial (877) 344-3890 (U.S. and Canada) or (760) 666-3770 (international) using conference ID number 11359260. To access the webcast, please visit the Investors section of KYTHERA’s website at www.kythera.com.